Cyclacel Pharmaceuticals Stock Analysis

Cyclacel Stock Analysis Notes

About 18.0% of the company shares are held by institutions such as insurance companies. The book value of Cyclacel Pharmaceuticals was currently reported as 0.57. The company recorded a loss per share of 27.4. Cyclacel Pharmaceuticals last dividend was issued on the 15th of April 2020. The entity had 1:15 split on the 18th of December 2023. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Cyclacel Pharmaceuticals please contact Spiro Rombotis at 908 517 7330 or go to https://www.cyclacel.com.

Cyclacel Pharmaceuticals Investment Alerts

Cyclacel Pharmaceuticals Upcoming and Recent Events

Cyclacel Largest EPS Surprises

View All Earnings Estimates

Cyclacel Stock Institutional Investors

Note, although Cyclacel Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cyclacel Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.55 M.

Cyclacel Profitablity

Management Efficiency

Cyclacel Pharmaceuticals has return on total asset (ROA) of (1.0253) % which means that it has lost $1.0253 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.7069) %, meaning that it created substantial loss on money invested by shareholders. Cyclacel Pharmaceuticals' management efficiency ratios could be used to measure how well Cyclacel Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.43. The current year's Return On Capital Employed is expected to grow to -37.55. At present, Cyclacel Pharmaceuticals' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 4.3 M, whereas Total Assets are forecasted to decline to about 8.4 M.

Technical Drivers

As of the 30th of November, Cyclacel Pharmaceuticals shows the risk adjusted performance of (0.11), and Mean Deviation of 5.31. Cyclacel Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cyclacel Pharmaceuticals Price Movement Analysis

Cyclacel Pharmaceuticals Insider Trading Activities

Cyclacel Pharmaceuticals Outstanding Bonds

Cyclacel Pharmaceuticals Predictive Daily Indicators

Cyclacel Pharmaceuticals Forecast Models

Cyclacel Pharmaceuticals' time-series forecasting models are one of many Cyclacel Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cyclacel Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cyclacel Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cyclacel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cyclacel Pharmaceuticals. By using and applying Cyclacel Stock analysis, traders can create a robust methodology for identifying Cyclacel entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cyclacel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cyclacel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cyclacel Pharmaceuticals stock analysis indicators help investors evaluate how Cyclacel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cyclacel Pharmaceuticals shares will generate the highest return on investment. By understating and applying Cyclacel Pharmaceuticals stock analysis, traders can identify Cyclacel Pharmaceuticals position entry and exit signals to maximize returns.

When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.